137
Views
1
CrossRef citations to date
0
Altmetric
Cardiology

Factors of Hospital Mortality in Men and Women with ST-Elevation Myocardial Infarction – An Observational, Retrospective, Single Centre Study

ORCID Icon, ORCID Icon & ORCID Icon
Pages 5955-5968 | Received 08 Sep 2023, Accepted 23 Nov 2023, Published online: 17 Dec 2023

References

  • Takagi K, Tanaka A, Yoshioka N, et al. In-hospital mortality among consecutive patients with ST-Elevation myocardial infarction in modern primary percutaneous intervention era ~ Insights from 15-year data of single-center hospital-based registry. PLoS One. 2021;16(6):e0252503. doi:10.1371/journal.pone.0252503
  • Zeymer U, Ludman P, Danchin N, et al.; On behalf of the ACVC EAPCI EORP ACS STEMI investigators group of the ESC. Reperfusion therapies and in-hospital outcomes for ST-elevation myocardial infarction in Europe: the ACVC-EAPCI EORP STEMI Registry of the European Society of Cardiology. Eur Heart J. 2021;42(44):4536–4549. doi:10.1093/eurheartj/ehab342
  • Timmis A, Townsend N, Gale CP, et al. European Society of Cardiology: cardiovascular Disease Statistics 2019 On behalf of the Atlas Writing Group The ESC Atlas of Cardiology is a compendium of cardiovascular statistics compiled by the European Heart Agency, a department of the European Society of Cardiology Developed in collaboration with the national societies of the European Society of Cardiology member countries. Eur Heart J. 2020;41(1):12–85. doi:10.1093/eurheartj/ehz859
  • Bauer D, Toušek P. Risk stratification of patients with acute coronary syndrome. J Clin Med. 2021;10(19):4574. doi:10.3390/jcm10194574
  • Ibanez B, Agewall J, Antunes MJ, et al. 2017 ESC Guidelines for the management of acute al infarction in patients presenting with ST-segment elevation The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2018;39(2):119–177. doi:10.1093/eurheartj/ehx393
  • Morrow DA, Antman EM, Charlesworth A, et al. TIMI risk score for ST-elevation myocardial infarction: a convenient, bedside, clinical score for risk assessment at presentation an intravenous nPA for treatment of infarcting myocardium early II Trial Substudy. Circulation. 2000;102(17):2031–2037. doi:10.1161/01.CIR.102.17.2031
  • Hess EP, Agarwal D, Chandra S, et al. Diagnostic accuracy of the TIMI risk score in patients with chest pain in the emergency department: a meta-analysis. CMAJ. 2010;182(10):1039–1044. doi:10.1503/cmaj.092119
  • Zorbozan O, Cevik AA, Acar N, et al. Predictors of mortality in ST-elevation MI patients. A prospective study. Medicine. 2018;97(9):e0065. doi:10.1097/MD.0000000000010065
  • Mehta RH, F-S O, Peterson ED, et al; American College of Cardiology-National Cardiovascular Database Registry Investigators. Clinical significance of post-procedural timi flow in patients with cardiogenic shock undergoing primary percutaneous coronary intervention. JACC. 2009;2(1):56–64. doi:10.1016/j.jcin.2008.10.006
  • Kammler J, Kypta A, Hofmann R, et al. TIMI 3 flow after primary angioplasty is an important predictor for outcome in patients with acute myocardial infarction. Clin Res Cardiol. 2009;98(3):165–170. doi:10.1007/s00392-008-0735-9
  • Bărcan A, Chițu M, Benedek E, et al. Predictors of mortality in patients with ST-segment elevation acute myocardial infarction and resuscitated out-of-hospital cardiac arrest. J Crit Care Med. 2016;2(1):22–29. doi:10.1515/jccm-2016-0001
  • Xi Z, Qiu H, Guo T, et al. Contemporary sex differences in mortality among patients with STsegment elevation myocardial infarction: a systematic review and meta-analysis. BMJ Open. 2022;12:e053379.
  • Bugiardini R, Ricci B, Cenko E, et al. Delayed Care and Mortality Among Women and Men With Myocardial Infarction. J Am Heart Assoc. 2017;6:e005968.
  • Khan E, Brieger D, Amerena J, et al. Differences in management and outcomes for men and women with ST-elevation myocardial infarction. Med J Aust. 2018;209(3):118–123. doi:10.5694/mja17.01109
  • Kanič V, Vollrath M, Tapajner A, Sinkovic A. Sex-related 30-day and long-term mortality in acute myocardial infarction patients treated with percutaneous coronary intervention. J Women’s Health. 2017;26(4):374–379. doi:10.1089/jwh.2016.5957
  • Killip T, Kimball JT. Treatment of myocardial infarction in a coronary care unit. A two year experience with 250 patients. Am J Cardiol. 1967;20(4):457–464. doi:10.1016/0002-9149(67)90023-9
  • Levey AS. Defining AKD: the spectrum of AKI, AKD, and CKD. Nephron. 2022;146(3):302–305. doi:10.1159/000516647
  • Kellum JA, Romagnani P, Ashuntantang G, Ronco C, Zarbock A, Anders H-J. Acute kidney injury. Nat Rev Dis Primers. 2021;7(1):52. doi:10.1038/s41572-021-00284-z
  • Steg PG, Huber K, Andreotti F, et al. Bleeding in acute coronary syndromes and percutaneous coronary interventions: position paper by the Working Group on Thrombosis of the European Society of Cardiology. Eur Heart J. 2011;32(15):1854–1864. doi:10.1093/eurheartj/ehr204
  • Calandra T, Cohen J. The international sepsis forum consensus conference on definitions of infection in the intensive care unit. Crit Care Med. 2005;33(7):538–548. doi:10.1097/01.CCM.0000168253.91200.83
  • van der Meer MG, Nathoe HM, van der Graaf Y, Doevendans PA, Appelman Y. Worse outcome in women with STEMI: a systematic review of prognostic studies. Eur J Clin Invest. 2015;45(2):226–235. doi:10.1111/eci.12399
  • Gök G, Çoner A, Çınar T, et al. Evaluation of demographic and clinical characteristics of female patients presenting with MINOCA and differences between male patients: a subgroup analysis of MINOCA-TR registry. Turk Kardiyol Dern Ars. 2022;50(1):4–13. doi:10.5543/tkda.2022.86219
  • Kumar S, McDaniel M, Samady H, Forouzandeh F. Contemporary Revascularization Dilemmas in Older Adults. J Am Heart Assoc. 2020;9(3):e014477. doi:10.1161/JAHA.119.014477
  • Cenko E, Yoon J, Kedev S, et al. Sex differences in outcomes after STEMI effect modification by treatment strategy and age. JAMA Intern Med. 2018;178(5):632–639. doi:10.1001/jamainternmed.2018.0514
  • Sabbag A, Matetzky S, Porter A, et al. Sex differences in the management and 5-Year outcome of young patients (<55 Years) with acute coronary syndromes. Am J Med. 2017;130(11):1324.e15–22. doi:10.1016/j.amjmed.2017.05.028
  • Scholz KH, Maier SKG, Maier LS, et al. Impact of treatment delay on mortality in ST-segment elevation myocardial infarction (STEMI) patients presenting with and without haemodynamic instability: results from the German prospective, multicentre FITT-STEMI trial. Eur Heart J. 2018;39(13):1065–1074. doi:10.1093/eurheartj/ehy004
  • Elakabawi K, Huang X, Shah SA, et al. Predictors of suboptimal coronary blood flow after primary angioplasty and its implications on short-term outcomes in patients with acute anterior STEMI. BMC Cardiovasc Disorders. 2020;20(1):391. doi:10.1186/s12872-020-01673-0
  • Manzi MV, Buccheri S, Jolly SS, et al. Sex-related differences in thrombus burden in STEMI patients undergoing primary percutaneous coronary intervention. JACC. 2022;15(20):2066–2076. doi:10.1016/j.jcin.2022.08.013
  • Bertic M, Fordyce CB, Moghaddam N, et al. Association of left anterior descending artery involvement on clinical outcomes among patients with STEMI presenting with and without out-of-hospital cardiac arrest. Open Heart. 2020;7:e001065.
  • Karam N, Bataille S, Marijon E, et al. For the e-MUST study investigators, incidence, mortality, and outcome-predictors of sudden cardiac arrest complicating myocardial infarction prior to hospital admission. Circ Cardiovasc Interv. 2019;12:e007081.
  • Jenča D, Melenovský V, Stehlik J, et al. Heart failure after myocardial infarction: incidence and predictors. EHJ Heart Fail. 2021;8(1):222–237. doi:10.1002/ehf2.13144
  • Wei J, Henry TD. Gender equity in STEMI: not so simple! Catheter Cardiovasc Interv. 2015;85(3):369–370. doi:10.1002/ccd.25800
  • Yu J, Mehran R, Grinfeld L, et al. Sex-based differences in bleeding and long term adverse events after percutaneous coronary intervention for acute myocardial infarction: three year results from the HORIZONS-AMI trial. Catheter Cardiovasc Interv. 2015;85(3):359–368. doi:10.1002/ccd.25630
  • Lindholm D, Sarno G, Erlinge D, et al. Combined association of key risk factors on ischaemic outcomes and bleeding in patients with myocardial infarction. Heart. 2019;105(15):1175–1181. doi:10.1136/heartjnl-2018-314590
  • Matsuura Y, Moribayashi K, Kaikita K. Optimal antithrombotic therapy in patients undergoing percutaneous coronary intervention: a focused review on high bleeding risk. J Atheroscler Thromb. 2022;29(10):1409–1420. doi:10.5551/jat.RV17066
  • Valgimigli M, Gragnano F. The benefit and harm of treating STEMI: between ischemia, bleeding, and reperfusion injury. Eur Heart J. 2020;9:259–261.
  • Gargiulo G, Giacoppo D, Jolly SS, et al. Effects on mortality and major bleeding of radial versus femoral artery access for coronary angiography or percutaneous coronary intervention: meta-analysis of individual patient data from 7 multicenter randomized clinical trials. Circulation. 2022;146(18):1329–1343. doi:10.1161/CIRCULATIONAHA.122.061527
  • Tersalvi G, Biasco L, Cio GM, Pedrazzini G. Acute coronary syndrome, antiplatelet therapy, and bleeding: a clinical perspective. J Clin Med. 2020;9(7):2064. doi:10.3390/jcm9072064
  • Frydman S, Freund O, Banai A, Zornitzki L, Banai S, Shacham Y. Relation of gender to the occurrence of AKI in STEMI patients. J Clin Med. 2022;11(21):6565. doi:10.3390/jcm11216565